LISATA THERAPEUTICS, INC. Future Amortization Expense, after Year Five (Deprecated 2012-01-31)
LISATA THERAPEUTICS, INC. (LSTA) reported Future Amortization Expense, after Year Five (Deprecated 2012-01-31) of $11.45 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseAfterYearFive · last filed 2013-05-09
- LISATA THERAPEUTICS, INC. future amortization expense, after year five (deprecated 2012-01-31) for the quarter ending 2013-03-31 was $11.45M.
- LISATA THERAPEUTICS, INC. future amortization expense, after year five (deprecated 2012-01-31) for fiscal 2012 was $11.50K.
| Period end | Future Amortization Expense, after Year Five (Deprecated 2012-01-31) 3 month | Future Amortization Expense, after Year Five (Deprecated 2012-01-31) 12 month |
|---|---|---|
| 2013-03-31 | $11.45M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $11.50K 10-K · filed 2013-03-11 | |
| 2011-12-31 | $12.06M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |